Viewing Study NCT00002406


Ignite Creation Date: 2025-12-26 @ 5:18 PM
Ignite Modification Date: 2026-01-27 @ 1:20 AM
Study NCT ID: NCT00002406
Status: COMPLETED
Last Update Posted: 2005-06-24
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV-1 View
None Dose-Response Relationship, Drug View
None HIV Protease Inhibitors View
None Indinavir View
None RNA, Viral View
None Reverse Transcriptase Inhibitors View